Nomura Holdings’s Ibere Pharmaceuticals IBER Stock Holding History

Nomura Holdings’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-318,644	Closed	-$3.21M	–	1925
2022 Q4	$3.21M	Hold	318,644	–	–	0.01%	606
2022 Q3	$3.15M	Buy	318,644 +9,218	+3%	+$90.9K	0.01%	693
2022 Q2	$3.04M	Buy	309,426 +25,740	+9%	+$252K	0.01%	684
2022 Q1	$2.77M	Hold	283,686	–	–	0.01%	795
2021 Q4	$2.75M	Hold	283,686	–	–	0.01%	899
2021 Q3	$2.74M	Hold	283,686	–	–	0.01%	819
2021 Q2	$2.75M	Buy	+283,686	New	+$2.76M	0.01%	759

Nomura Holdings's IBER Position: Q1 2023 in Review

Nomura Holdings sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 318,644 shares — an estimated $3.21M sold.

Nomura Holdings first reported a position in IBER in Q2 2021 and held it in 7 quarters. The position peaked at $3.21M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Nomura Holdings reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Nomura Holdings sold 318,644 Ibere Pharmaceuticals shares in Q1 2023, an estimated $3.21M.
Nomura Holdings first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Nomura Holdings's Ibere Pharmaceuticals position peaked at $3.21M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.